184 related articles for article (PubMed ID: 30457103)
1. A stochastic epigenetic switch controls the dynamics of T-cell lineage commitment.
Ng KK; Yui MA; Mehta A; Siu S; Irwin B; Pease S; Hirose S; Elowitz MB; Rothenberg EV; Kueh HY
Elife; 2018 Nov; 7():. PubMed ID: 30457103
[TBL] [Abstract][Full Text] [Related]
2. Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment.
Kueh HY; Yui MA; Ng KK; Pease SS; Zhang JA; Damle SS; Freedman G; Siu S; Bernstein ID; Elowitz MB; Rothenberg EV
Nat Immunol; 2016 Aug; 17(8):956-65. PubMed ID: 27376470
[TBL] [Abstract][Full Text] [Related]
3. Bcl11b and combinatorial resolution of cell fate in the T-cell gene regulatory network.
Longabaugh WJR; Zeng W; Zhang JA; Hosokawa H; Jansen CS; Li L; Romero-Wolf M; Liu P; Kueh HY; Mortazavi A; Rothenberg EV
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):5800-5807. PubMed ID: 28584128
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Dynamics in the Function of T-Lineage Regulatory Factor Bcl11b.
Sidwell T; Rothenberg EV
Front Immunol; 2021; 12():669498. PubMed ID: 33936112
[TBL] [Abstract][Full Text] [Related]
5. Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytes.
Kojo S; Tanaka H; Endo TA; Muroi S; Liu Y; Seo W; Tenno M; Kakugawa K; Naoe Y; Nair K; Moro K; Katsuragi Y; Kanai A; Inaba T; Egawa T; Venkatesh B; Minoda A; Kominami R; Taniuchi I
Nat Commun; 2017 Sep; 8(1):702. PubMed ID: 28951542
[TBL] [Abstract][Full Text] [Related]
6. Tunable, division-independent control of gene activation timing by a polycomb switch.
Pease NA; Nguyen PHB; Woodworth MA; Ng KKH; Irwin B; Vaughan JC; Kueh HY
Cell Rep; 2021 Mar; 34(12):108888. PubMed ID: 33761349
[TBL] [Abstract][Full Text] [Related]
7. BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.
Cismasiu VB; Duque J; Paskaleva E; Califano D; Ghanta S; Young HA; Avram D
Biochem J; 2009 Jan; 417(2):457-66. PubMed ID: 18831712
[TBL] [Abstract][Full Text] [Related]
8. Single-cell deletion analyses show control of pro-T cell developmental speed and pathways by Tcf7, Spi1, Gata3, Bcl11a, Erg, and Bcl11b.
Zhou W; Gao F; Romero-Wolf M; Jo S; Rothenberg EV
Sci Immunol; 2022 May; 7(71):eabm1920. PubMed ID: 35594339
[TBL] [Abstract][Full Text] [Related]
9. Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate.
Isoda T; Moore AJ; He Z; Chandra V; Aida M; Denholtz M; Piet van Hamburg J; Fisch KM; Chang AN; Fahl SP; Wiest DL; Murre C
Cell; 2017 Sep; 171(1):103-119.e18. PubMed ID: 28938112
[TBL] [Abstract][Full Text] [Related]
10. Transformation of Accessible Chromatin and 3D Nucleome Underlies Lineage Commitment of Early T Cells.
Hu G; Cui K; Fang D; Hirose S; Wang X; Wangsa D; Jin W; Ried T; Liu P; Zhu J; Rothenberg EV; Zhao K
Immunity; 2018 Feb; 48(2):227-242.e8. PubMed ID: 29466755
[TBL] [Abstract][Full Text] [Related]
11. Bcl11b transcription factor plays a role in the maintenance of the ameloblast-progenitors in mouse adult maxillary incisors.
Katsuragi Y; Anraku J; Nakatomi M; Ida-Yonemochi H; Obata M; Mishima Y; Sakuraba Y; Gondo Y; Kodama Y; Nishikawa A; Takagi R; Ohshima H; Kominami R
Mech Dev; 2013; 130(9-10):482-92. PubMed ID: 23727454
[TBL] [Abstract][Full Text] [Related]
12. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.
Huang X; Chen S; Shen Q; Chen S; Yang L; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
Hematology; 2011 Jul; 16(4):236-42. PubMed ID: 21756541
[TBL] [Abstract][Full Text] [Related]
13. Partially compromised specification causes stochastic effects on gut development in C. elegans.
Choi H; Broitman-Maduro G; Maduro MF
Dev Biol; 2017 Jul; 427(1):49-60. PubMed ID: 28502614
[TBL] [Abstract][Full Text] [Related]
14. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
[TBL] [Abstract][Full Text] [Related]
15. Cell type-specific actions of Bcl11b in early T-lineage and group 2 innate lymphoid cells.
Hosokawa H; Romero-Wolf M; Yang Q; Motomura Y; Levanon D; Groner Y; Moro K; Tanaka T; Rothenberg EV
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31653691
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development.
Yu Y; Wang C; Clare S; Wang J; Lee SC; Brandt C; Burke S; Lu L; He D; Jenkins NA; Copeland NG; Dougan G; Liu P
J Exp Med; 2015 Jun; 212(6):865-74. PubMed ID: 25964371
[TBL] [Abstract][Full Text] [Related]
17. An essential developmental checkpoint for production of the T cell lineage.
Ikawa T; Hirose S; Masuda K; Kakugawa K; Satoh R; Shibano-Satoh A; Kominami R; Katsura Y; Kawamoto H
Science; 2010 Jul; 329(5987):93-6. PubMed ID: 20595615
[TBL] [Abstract][Full Text] [Related]
18. T Cell Development by the Numbers.
Krueger A; Ziętara N; Łyszkiewicz M
Trends Immunol; 2017 Feb; 38(2):128-139. PubMed ID: 27842955
[TBL] [Abstract][Full Text] [Related]
19. BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma.
Fu W; Yi S; Qiu L; Sun J; Tu P; Wang Y
J Invest Dermatol; 2017 Jul; 137(7):1523-1532. PubMed ID: 28288848
[TBL] [Abstract][Full Text] [Related]
20. BCL11B tumor suppressor inhibits HDM2 expression in a p53-dependent manner.
Obata M; Kominami R; Mishima Y
Cell Signal; 2012 May; 24(5):1047-52. PubMed ID: 22245141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
